381 related articles for article (PubMed ID: 26409796)
1. N-acetyltransferase 1 and 2 polymorphisms and risk of diabetes mellitus type 2 in a Saudi population.
Al-Shaqha WM; Alkharfy KM; Al-Daghri NM; Mohammed AK
Ann Saudi Med; 2015; 35(3):214-21. PubMed ID: 26409796
[TBL] [Abstract][Full Text] [Related]
2. N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.
Mishra S; Daschakraborty S; Shukla P; Kapoor P; Aggarwal R
Natl Med J India; 2013; 26(5):260-5. PubMed ID: 25017831
[TBL] [Abstract][Full Text] [Related]
3. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
4. Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma.
Prawan A; Kukongviriyapan V; Tassaneeyakul W; Pairojkul C; Bhudhisawasdi V
Eur J Cancer Prev; 2005 Jun; 14(3):245-50. PubMed ID: 15901993
[TBL] [Abstract][Full Text] [Related]
5. TaqMan real time-polymerase chain reaction methods for determination of nucleotide polymorphisms in human N-acetyltransferase-1 (NAT1) and -2 (NAT2).
Hein DW; Doll MA
Curr Protoc Toxicol; 2005; Chapter 4():Unit4.15. PubMed ID: 23045122
[TBL] [Abstract][Full Text] [Related]
6. Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1 and L1CAM in the Japanese population.
Sekine A; Saito S; Iida A; Mitsunobu Y; Higuchi S; Harigae S; Nakamura Y
J Hum Genet; 2001; 46(6):314-9. PubMed ID: 11393533
[TBL] [Abstract][Full Text] [Related]
7. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
Cascorbi I; Roots I; Brockmöller J
Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340
[TBL] [Abstract][Full Text] [Related]
8. Association of NAT2 polymorphisms with type 2 diabetes in a population from Bosnia and Herzegovina.
Semiz S; Dujic T; Ostanek B; Velija-Asimi Z; Prnjavorac B; Bego T; Malenica M; Mlinar B; Heljic B; Marc J; Causevic A
Arch Med Res; 2011 May; 42(4):311-7. PubMed ID: 21820610
[TBL] [Abstract][Full Text] [Related]
9. The MCP-1 Gene A-2518G Polymorphism Confers an Increased Risk of Vascular Complications in Type 2 Diabetes Mellitus Patients.
Xu J; Liao YF; Zhou WP; Ming HL; Wang QH
Genet Test Mol Biomarkers; 2015 Aug; 19(8):411-7. PubMed ID: 26083329
[TBL] [Abstract][Full Text] [Related]
10. N-acetyltransferase 2 gene polymorphism and presbycusis.
Unal M; Tamer L; Doğruer ZN; Yildirim H; Vayisoğlu Y; Camdeviren H
Laryngoscope; 2005 Dec; 115(12):2238-41. PubMed ID: 16369173
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between endometriosis and N-acetyl transferase 1 (NAT1) and 2 (NAT2) polymorphisms in a Japanese population.
Deguchi M; Yoshida S; Kennedy S; Ohara N; Motoyama S; Maruo T
J Soc Gynecol Investig; 2005 Apr; 12(3):208-13. PubMed ID: 15784508
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility.
Varzim G; Monteiro E; Silva R; Pinheiro C; Lopes C
ORL J Otorhinolaryngol Relat Spec; 2002; 64(3):206-12. PubMed ID: 12037388
[TBL] [Abstract][Full Text] [Related]
13. N-acetyltransferase 1 and 2 polymorphisms in para-substituted arylamine-induced contact allergy.
Westphal GA; Reich K; Schulz TG; Neumann C; Hallier E; Schnuch A
Br J Dermatol; 2000 Jun; 142(6):1121-7. PubMed ID: 10848734
[TBL] [Abstract][Full Text] [Related]
14.
Dursun R; Dursun HG; Zamani AG; Yıldırım MS; Çınar İ
Biomed Res Int; 2018; 2018():3258708. PubMed ID: 29992137
[TBL] [Abstract][Full Text] [Related]
15. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.
Wikman H; Thiel S; Jäger B; Schmezer P; Spiegelhalder B; Edler L; Dienemann H; Kayser K; Schulz V; Drings P; Bartsch H; Risch A
Pharmacogenetics; 2001 Mar; 11(2):157-68. PubMed ID: 11266080
[TBL] [Abstract][Full Text] [Related]
16. Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer.
Majumder M; Ghosh S; Roy B
Indian J Med Res; 2012 Oct; 136(4):605-13. PubMed ID: 23168701
[TBL] [Abstract][Full Text] [Related]
17. Association of NAT1 and NAT2 genes with nonsyndromic cleft lip and palate.
Song T; Wu D; Wang Y; Li H; Yin N; Zhao Z
Mol Med Rep; 2013 Jul; 8(1):211-6. PubMed ID: 23660777
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.
Morton LM; Schenk M; Hein DW; Davis S; Zahm SH; Cozen W; Cerhan JR; Hartge P; Welch R; Chanock SJ; Rothman N; Wang SS
Pharmacogenet Genomics; 2006 Aug; 16(8):537-45. PubMed ID: 16847422
[TBL] [Abstract][Full Text] [Related]
19. N-acetyltransferase 2 polymorphism in patients with diabetes mellitus.
Yalin S; Hatungil R; Tamer L; Ates NA; Dogruer N; Yildirim H; Karakas S; Atik U
Cell Biochem Funct; 2007; 25(4):407-11. PubMed ID: 16397907
[TBL] [Abstract][Full Text] [Related]
20. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
